An Alternative Elastase-mediated Degradation of Fibrinogen and Fibrin Observed in a Patient with Herpes Simplex Encephalitis and Pneumonia

Summary

A 74-year-old female developed pneumonia following herpes simplex encephalitis. Her white blood cell counts reached 28,400/μl, about 90% of which consisted of granulocytes. The polymorphonuclear (PMN) elastase/α₁-arantitrypsin complex levels increased and reached the maximum of 5,019 ng/ml, indicating the release of a large amount of elastase derived from the granulocytes. The mechanism of PMN elastase release was most likely to be granulocyte destruction associated with phagocytosis. The cleavage of fibrinogen and fibrin by PMN elastase, independent of plasmin, was indicated by the presence of the fragments in immunoprecipitated plasma from the patient corresponding to elastase-induced FDP D and DD fragments and the absence of fragments corresponding to plasmin-induced FDP D and DD fragments on SDS-PAGE. These findings suggested that the large amount of PMN elastase released from the excessive numbers of granulocytes in this patient with herpes simplex encephalitis and pneumonia, induced the cleavage of fibrinogen and fibrin without the participation of plasmin.

• References

• 1 Francis CW, Marder VJ, Martin SE. Plasmic degradation of crosslinked fibrin. I. Structural analysis of the particulate clot and identification of new macromolecular-soluble complex. Blood 1980; 56: 456-464
• 2 Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastase. Eur J Biochem 1974; 42: 519-527
• 3 Ohlsson K, Olsson I. The neutral proteases of human granulocytes. Isolation and partial characterization of two granulocyte collagenases. Eur JBiochem 1973; 36: 473-481
• 4 Schmidt W, Havemann K. Isolation of elastase-like and chymotrypsin-like neutral proteases from human granulocytes. Hoppe-Seylers Z Physiol Chem 1974; 355: 1077-1082
• 5 Plow EF. The major fibrinolytic proteases of human leukocytes. Biochem Biophys Acta 1980; 630: 47-56
• 6 Ohlsson K, Olsson I. Neutral proteases of human granulocyte elastase and plasma protein inhibitors. Scand J Clin Lab Invest 1974; 34: 349-355
• 7 Brower MS, Harpel PC. Alpha-1-antitrypsin-human leukocyte elastase complexes in blood: Quantification by an enzyme-linked differential antibody immunosorbent assay and comparison with alphaM₂-plasmin inhibitor-plasmin complexes. Blood 1983; 61: 842-849
• 8 Egbring R, Seitz R, Blanke H, Leititis J, Kesper J, Burghard R, Fuchs G, Lerch L. The proteinase inhibitor complexes (antithrombin III-thrombin, α₂-antiplasmin-plasmin and α₁-antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock. Value for diagnosis and therapy control in DIC/F syndrome. Behring Inst Mitt 1986; 79: 87-103
• 9 Seitz R, Wolf M, Egbring R, Radtke K-P, Liesenfeld A, Pittner P, Havemann K. Participation and interactions of neutrophil elastase in haemostatic of patients with severe infections. Eur J Haematol 1987; 38: 231-240
• 10 Nuijens JH, Abbink JJ, Wachtfogel YT, Colman RW, Eerenberg JM, Dors D, Kamp AJM, Strack van SchijndelRJM, Thijs LG, Hack CE. Plasma elastase α₁-antitrypsin and lactoferrin in sepsis: Evidence for neutrophils as mediators in fatal sepsis. J Lab Clin Med 1992; 119: 159-168
• 11 Plow EF, Edgington TS. An alternative pathway for fibrinolysis. I. The cleavage of fibrinogen by leukocyte proteases at physiologic pH. J Clin Invest 1975; 56: 30-38
• 12 Bilezikian SB, Nossel HL. Unique pattern of fibrinogen cleavage by human leukocyte proteases. Blood 1977; 50: 21-28
• 13 Gramse M, Bingenheimer C, Schmidt W, Egbring R, Havemann K. Degradation products of fibrinogen by elastase-like neutral protease from human granulocytes. J Clin Invest 1978; 61: 1027-1033
• 14 Matsuda M, Terukina S, Yamazumi K, Maekawa H, Soe G. A monoclonal antibody that recognized the NH2-terminal conformation of Fragment D. In: Fibrinogen 4. Current basic and clinical aspects Matsuda M, Iwanaga S, Takada A, HenschenE A. (eds) Amsterdam, Netherlands: Elsevier Science Publishers B.V. (Biomedical Division); 1990: 43-48
• 15 Masci PP, Whitaker AN, Winzor DJ. A simple chromatographic procedure for the purification of the D dimer fragment from crosslinked fibrin. Anal Biochem 1985; 147: 128-135
• 16 Olexa SA, Budzynski AZ. Primary soluble plasmic degradation products of human crosslinked fibrin. Isolation and stoichiometry of the (DD) E. Biochemistry 1979; 18: 991-995
• 17 Henry RL. Leukocytes and thrombosis. Thromb Diath Haemorrh 1965; 13: 35-46
• 18 Ohlsson K, Olsson I. The extracellular release of granulocyte collagenase and elastase during phagocytosis and inflammatory process. Scand J Haematol 1977; 19: 145-152
• 19 Henson PM. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytos-able particles. J Immunol 1971; 107: 1535-1546
• 20 Henson PM. The immunologic release of constituents from neutrophil leukocytes. II. Mechanisms of release during phagocytosis, and adherence to nonphagocytosable surfaces. J Immunol 1971; 107: 1547-1557
• 21 Plow EF. Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. J Clin Invest 1982; 69: 564-572
• 22 Bach-Gasmo ET, Halvorsen S, Godal HS, Skpnsberg OH. Impaired coagulation of fibrinogen due to digestion of the C-terminal end of the Aα-chain by human neutrophil elastase. Thromb Res 1994; 73: 61-68